VPC 14449
CAS No. 1621375-32-3
VPC 14449 ( VPC14449 )
Catalog No. M12386 CAS No. 1621375-32-3
VPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 224 | Get Quote |
|
50MG | 897 | Get Quote |
|
100MG | 1386 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVPC 14449
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM.
-
DescriptionVPC 14449 is a potent and selective androgen receptor DNA-binding domain (AR-DBD) inhibitor with IC50 of 0.34 uM, without affecting AR protein expression; effectively blocks transcriptional activity of full-length and splice variant AR forms at low to sub-micromolar concentrations; reduces tumor volume and abolishes PSA production in LNCaP xenograft model.
-
SynonymsVPC14449
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor (AR)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1621375-32-3
-
Formula Weight394.09
-
Molecular FormulaC10H10Br2N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESBrC1=C(Br)N=CN1C2=CSC(N3CCOCC3)=N2
-
Chemical Name4-(4-(4,5-dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dalal K, et al. Mol Cancer Ther. 2017 Aug 3. pii: molcanther.0259.2017.
2. Dalal K, et al. J Biol Chem. 2014 Sep 19;289(38):26417-29.
2. Dalal K, et al. J Biol Chem. 2014 Sep 19;289(38):26417-29.
molnova catalog
related products
-
LGD-3303
LGD-3303 is an orally available, brain-penetrant nonsteroidal selective androgen receptor modulator (SARM) that that shows little or no cross-reactivity with related nuclear receptors.
-
Flutamide
Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
-
Ailanthone
Ailanthone is an effective inhibitor of both full-length androgen receptor (AR) (IC50: 69?nM) and constitutively active truncated AR splice variants (IC50: 309?nM).